Abstract
Strategy of using multiple mRNA shots to hone powerful antibodies hits a pothole.
MeSH terms
-
AIDS Vaccines* / adverse effects
-
AIDS Vaccines* / immunology
-
Antibodies, Neutralizing / immunology
-
Clinical Trials, Phase I as Topic
-
HIV Antibodies / immunology
-
HIV Infections* / prevention & control
-
Humans
-
National Institute of Allergy and Infectious Diseases (U.S.)
-
Skin Diseases* / etiology
-
United States
-
mRNA Vaccines* / adverse effects
Substances
-
AIDS Vaccines
-
Antibodies, Neutralizing
-
HIV Antibodies
-
mRNA Vaccines